Cutler Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $893K | Sell |
6,900
-11,634
| -63% | -$1.51M | 0.29% | 55 |
|
|
2023
Q4 | $1.79M | Sell |
18,534
-5,481
| -23% | -$528K | 0.16% | 90 |
|
|
2023
Q3 | $2.91M | Buy |
24,015
+2,524
| +12% | +$306K | 0.3% | 54 |
|
|
2023
Q2 | $2.46M | Buy |
21,491
+30
| +0.1% | +$3.44K | 0.34% | 43 |
|
|
2023
Q1 | $2.96M | Buy |
21,461
+7,761
| +57% | +$1.07M | 0.31% | 55 |
|
|
2022
Q4 | $1.78M | Buy |
13,700
+1,800
| +15% | +$233K | 0.15% | 110 |
|
|
2022
Q3 | $1.32M | Sell |
11,900
-5,985
| -33% | -$661K | 0.09% | 123 |
|
|
2022
Q2 | $1.34M | Buy |
17,885
+7,735
| +76% | +$580K | 0.09% | 139 |
|
|
2022
Q1 | $792K | Sell |
10,150
-22,680
| -69% | -$1.77M | 0.04% | 260 |
|
|
2021
Q4 | $2.96M | Buy |
32,830
+7,330
| +29% | +$660K | 0.12% | 107 |
|
|
2021
Q3 | $2.36M | Buy |
25,500
+21,600
| +554% | +$2M | 0.11% | 130 |
|
|
2021
Q2 | $303K | Sell |
3,900
-4,664
| -54% | -$362K | 0.01% | 580 |
|
|
2021
Q1 | $638K | Buy |
+8,564
| New | +$638K | 0.03% | 353 |
|
|
2020
Q4 | – | Sell |
-2,300
| Closed | -$322K | – | 2333 |
|
|
2020
Q3 | $322K | Buy |
+2,300
| New | +$322K | 0.02% | 381 |
|
|
2020
Q2 | – | Sell |
-5,001
| Closed | -$489K | – | 2065 |
|
|
2020
Q1 | $489K | Sell |
5,001
-6,899
| -58% | -$675K | 0.03% | 265 |
|
|
2019
Q4 | $1.54M | Buy |
11,900
+2,100
| +21% | +$271K | 0.09% | 152 |
|
|
2019
Q3 | $738K | Sell |
9,800
-5,104
| -34% | -$384K | 0.07% | 186 |
|
|
2019
Q2 | $2.26M | Buy |
14,904
+8,804
| +144% | +$1.34M | 0.21% | 66 |
|
|
2019
Q1 | $727K | Sell |
6,100
-903
| -13% | -$108K | 0.08% | 195 |
|
|
2018
Q4 | $764K | Buy |
7,003
+6,700
| +2,211% | +$731K | 0.07% | 170 |
|
|
2018
Q3 | $48K | Sell |
303
-18,978
| -98% | -$3.01M | ﹤0.01% | 945 |
|
|
2018
Q2 | $2.55M | Buy |
19,281
+16,926
| +719% | +$2.24M | 0.2% | 81 |
|
|
2018
Q1 | $174K | Buy |
2,355
+2,011
| +585% | +$149K | 0.02% | 579 |
|
|
2017
Q4 | $19K | Sell |
344
-6,592
| -95% | -$364K | ﹤0.01% | 1410 |
|
|
2017
Q3 | $314K | Buy |
6,936
+783
| +13% | +$35.4K | 0.01% | 589 |
|
|
2017
Q2 | $207K | Buy |
6,153
+2,298
| +60% | +$77.3K | 0.01% | 846 |
|
|
2017
Q1 | $114K | Sell |
3,855
-110,040
| -97% | -$3.25M | ﹤0.01% | 1076 |
|
|
2016
Q4 | $3.12M | Buy |
113,895
+49,885
| +78% | +$1.37M | 0.11% | 94 |
|
|
2016
Q3 | $3.93M | Sell |
64,010
-91,192
| -59% | -$5.6M | 0.18% | 59 |
|
|
2016
Q2 | $2.96M | Buy |
155,202
+59,021
| +61% | +$1.13M | 0.15% | 74 |
|
|
2016
Q1 | $1.88M | Buy |
96,181
+54,107
| +129% | +$1.06M | 0.12% | 93 |
|
|
2015
Q4 | $1.62M | Buy |
+42,074
| New | +$1.62M | 0.09% | 138 |
|